Bifidobacteria supplementation: Effects on plasma lipid profiles in dyslipidemic children

Nutrition

Volumn 30, Issue 7-8, 2014, Pages 831-836

  Guardamagna, Ornella ^a   Amaretti, Alberto ^b   Puddu, Paolo Emilio ^c   Raimondi, Stefano ^b   Abello, Francesca ^a   Cagliero, Paola ^a   Rossi, Maddalena ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bifidobacterium; Child; Dyslipidemia; Hypercholesterolemia; Probiotics

Indexed keywords

CHOLESTEROL; CONJUGATED LINOLEIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; PROBIOTIC AGENT; SATURATED FATTY ACID; TRIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BILE SALT HYDROLYSIS; CHILD; CHOLESTEROL ASSIMILATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; DYSLIPIDEMIA; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYDROLYSIS; LIPID ANALYSIS; LIPID METABOLISM; MALE; MEDICATION COMPLIANCE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; BLOOD; HYPERCHOLESTEROLEMIA; SPECIES DIFFERENCE;

ANTICHOLESTEREMIC AGENTS; BIFIDOBACTERIUM; CHILD; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PROBIOTICS; SPECIES SPECIFICITY; TRIGLYCERIDES;

EID: 84903389434     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.01.014     Document Type: Article

References (29)

1. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011, 128:213-256. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute.
2. Guidelines for the evaluation of probiotics in food 2002, Joint FAO/WHO Working Group, FAO/WHO, London, Ontario, Canada.
3. Pompei A., Cordisco L., Amaretti A., Zanoni S., Raimondi S., Matteuzzi D., et al. Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J Nutr 2007, 137:2742-2746.
4. Amaretti A., di Nunzio M., Pompei A., Raimondi S., Rossi M., Bordoni A. Antioxidant properties of potentially probiotic bacteria: invitro and invivo activities. Appl Microbiol Biotechnol 2013, 97:809-817.
5. Bordoni A., Amaretti A., Leonardi A., Boschetti E., Danesi F., Matteuzzi D., et al. Cholesterol-lowering probiotics: invitro selection and invivo testing of bifidobacteria. Appl Microbiol Biotechnol 2013, 97:8273-8281.
6. Jones M.L., Tomaro-Duchesneau C., Martoni C.J., Prakash S. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther 2013, 13:631-642.
7. Kumar R., Grover S., Batish V.K. Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br J Nutr 2011, 105:561-573.
8. Ooi L.G., Liong M.T. Cholesterol-lowering effects of probiotics and prebiotics: a review of invivo and invitro findings. Int J Mol Sci 2010, 11:2499-2522.
9. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011, 94:3288-3294.
10. Dilzer A., Park Y. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr 2012, 52:488-513.
11. Ringseis R., Eder K. Influence of conjugated linoleic acids on functional properties of vascular cells. Br J Nutr 2009, 102:1099-1116.
12. Martino F., Puddu P.E., Pannarale G., Colantoni C., Zanoni C., Martino E., et al. Arterial blood pressure and serum lipids in a population of children and adolescents from southern Italy: the Calabrian Sierras Community Study (CSCS). Int J Cardiol 2013, 168:1108-1114.
13. Guardamagna O., Abello F., Anfossi G., Pirro M. Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias. J Pediatr 2011, 159:314-319.
14. Guo Z., Liu X.M., Zhang Q.X., Shen Z., Tian F.W., Zhang H., et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis ofrandomised controlled trials. Nutr Metab Cardiovasc Dis 2011, 21:844-850.
15. Jones M.L., Martoni C.J., Tamber S., Parent M., Prakash S. Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 2012, 50:2216-2223.
16. Fabian E., Elmadfa I. Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann Nutr Metab 2006, 50:387-393.
17. Ataie-Jafari A., Larijani B., Alavi Majd H., Tahbaz F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab 2009, 54:22-27.
18. Larkin T.A., Astheimer L.B., Price W.E. Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects. Eur J Clin Nutr 2009, 63:238-245.
19. Agerholm-Larsen L., Raben A., Haulrik N., Hansen A.S., Manders M., Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000, 54:288-297.
20. de Roos N.M., Schouten G., Katan M.B. Yogurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr 1999, 53:277-280.
21. Agerholme-Larsen L., Bell M.L., Grunwald G.K., Astrup A. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 2000, 54:856-860.
22. Anderson J.W., Gilliland S.E. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 1999, 18:43-50.
23. Sadrzadeh-Yeganeh H., Elmadfa I., Djazayery A., Jalali M., Heshmat R., Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 2010, 103:1778-1783.
24. Xiao J.Z., Kondo S., Takahashi N., Miyaji K., Oshida K., Hiramatsu A., et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 2003, 86:2452-2461.
25. Guardamagna O., Abello F., Cagliero P., Visioli F. Could dyslipidemic children benefit from glucomannan intake?. Nutrition 2013, 29:1060-1065.
26. Guardamagna O., Abello F., Baracco V., Federici G., Bertucci P., Mozzi A., et al. Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. Acta Diabetol 2011, 48:127-133.
27. Guardamagna O., Abello F., Baracco V., Stasiowska B., Martino F. The treatment of hypercholesterolemic children: Efficacy and safety of a combination of red yeast rice extract and policosanols. Nutr Metab Cardiovasc Dis 2011, 21:424-429.
28. Sanders M.E., Akkermans L.M., Haller D., Hammerman C., Heimbach J., Hörmannsperger G., et al. Safety assessment of probiotics for human use. Gut Microbes 2010, 1:164-185.
29. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2012 update). EFSA Journal 2012, 10:3020. European Food Safety Authority (EFSA).